Avadel pharmaceuticals appoints naseem amin, m.d. to its board of directors

Dublin, ireland, may 21, 2024 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a biopharmaceutical company focused on transforming medicines to transform lives, announced today the appointment of naseem amin, m.d. to its board of directors, effective may 17, 2024. dr. amin, a highly successful executive who brings global industry and leadership experience to avadel, currently serves as chief executive officer of orphalan sa.
AVDL Ratings Summary
AVDL Quant Ranking